{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:23:53Z","timestamp":1759962233978},"reference-count":44,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1185\/030079906x162827","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T05:38:28Z","timestamp":1169703508000},"page":"459-466","source":"Crossref","is-referenced-by-count":10,"title":["Role for 5\u2011day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis"],"prefix":"10.1185","volume":"23","author":[{"given":"Mark","family":"Gotfried","sequence":"first","affiliation":[{"name":"University of Arizona, Pulmonary Associates, Phoenix, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Busman","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, Abbott Park, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Norris","sequence":"additional","affiliation":[{"name":"Norris Communications, Grosse Pointe Farms, MI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard F.","family":"Notario","sequence":"additional","affiliation":[{"name":"Abbott Laboratories, Abbott Park, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2007,1,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.11.929.34523"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Blanchard AR. Treatment of COPD exacerbations. Pharmacologic options and modification of risk factors. Postgrad Med 2002;111:65\u20138, 71\u20132, 75","DOI":"10.3810\/pgm.2002.06.1226"},{"key":"CIT0003","unstructured":"Chodosh S. Bronchitis and asthma. In: Gorbach SL, Bartlett JL, and Blacklow NR, editors. Infectious Diseases. Philadelphia: W.B. Saunders Co. 1992. pp.476\u201385"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1053\/srin.2000.0150059"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Sethi S. Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 1999;43(Suppl A):97\u2013105","DOI":"10.1093\/jac\/43.suppl_1.97"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2002.1382"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.1999.0708"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88277-6"},{"key":"CIT0009","first-page":"314","volume":"12","author":"File T","year":"2002","journal-title":"The 070 Clinical Study group. J Chemother"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/45.6.851"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80033-3"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X26243"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2002.14.6.597"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00008-9"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(97)00043-5"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.1998.tb11633.x","volume":"52","author":"Langan C","year":"1998","journal-title":"Int J Clin Prac"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.4.515"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1159\/000048458"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00435-6"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62248-X"},{"key":"CIT0021","first-page":"441","volume":"17","author":"O\u2019Doherty B","year":"1998","journal-title":"R. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group. Eur J Clin Microbiol Infect Dis"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1742-1241.2000.tb11907.x","volume":"54","author":"Paster RZ","year":"2000","journal-title":"Int J Clin Prac"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1177\/147323000102900408"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Sethi S, Breton J, Wynne B. Efficacy and safety of pharmaco- kinetically enhanced amoxicillin-clavulanate at 2000\/125 milli- grams twice daily for 5 days versus amoxicillin-clavulanate at 875\/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis. Antimicrob Agents Chemother 2005;49: 153\u201360","DOI":"10.1128\/AAC.49.1.153-160.2005"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.4.501"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)85139-6"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363200-00002"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2004.03.003"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80060-6"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83040-4"},{"key":"CIT0031","doi-asserted-by":"crossref","unstructured":"Weiss K, Vanjaka A, Canadian Study Group on Bronchitis. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate- release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis. Clin Ther 2002;24: 2105\u201322","DOI":"10.1016\/S0149-2918(02)80100-X"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80062-X"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125002018"},{"key":"CIT0034","first-page":"932","volume":"23","author":"Celli BR","year":"2004","journal-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper. Eur Respir J"},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell DE, Aaron S, Bourbeau J, et al. State of the art compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004;11(Suppl B):7B\u201343","DOI":"10.1155\/2004\/946769"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2005.07.002"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-196"},{"key":"CIT0038","unstructured":"National Committee for Clinical Laboratory Standards (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved Standard NCCLS Document M7-A5 and 10th Informational Supplement: M100-S10 (M7)"},{"key":"CIT0039","unstructured":"National Committee for Clinical Laboratory Standards (2000). Performance standards for antimicrobial disk susceptibility tests. 7th ed. Approved Standard NCCLS Document M2-A7 and 10th Informational Supplement: M100-S10 (M2)"},{"key":"CIT0040","first-page":"689","volume":"10","author":"Brunton S","year":"2004","journal-title":"Am J Manag Care"},{"key":"CIT0041","doi-asserted-by":"crossref","unstructured":"Farrell DJ, File TM, Jenkins SG. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistantStreptococcus pneumoniaeover 4 years of the PROTEKT US Study (2000\u20132004). J Clin Microbiol 2006 Nov 8; [Epub ahead of print]","DOI":"10.1128\/JCM.01653-06"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.3.405"},{"key":"CIT0043","doi-asserted-by":"crossref","unstructured":"Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004;125(Suppl):52S\u201360","DOI":"10.1378\/chest.125.2_suppl.52S"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-6-200503210-00121"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X162827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T14:20:40Z","timestamp":1683728440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X162827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,23]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,1]]}},"alternative-id":["10.1185\/030079906X162827"],"URL":"https:\/\/doi.org\/10.1185\/030079906x162827","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,23]]}}}